Geron is tirelessly pursuing blood cancer treatments with the potential to extend and enhance lives.

2025年3月11日 · Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult …

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Powered by pioneering science, grounded in world-class expertise, and driven by purpose, Geron aims to change lives by changing the course of blood cancer. Nobel Prize-winning discoveries …

2024年11月7日 · FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing …

2016年3月5日 · Geron Corporation 是一家后期临床生物制药公司，专注于开发和商业化骨髓恶性血液病治疗药物。 该公司开发了端粒酶抑制剂 imetelstat，目前处于 3 期临床试验阶段，该药 …

Scientific research has shown that telomerase activity is increased in malignant stem and progenitor cells in the bone marrow. Inhibiting telomerase activity aims to potentially reduce …

2025年3月24日 · Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase …

2024年12月13日 · Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced …

Changing lives by changing the course of blood cancer. Geron is a biopharmaceutical company that is charting a new course with the goal to deliver innovative treatment options for people …